Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Sell
43,611
-21,093
-33% -$5.61M 0.06% 281
2026
Q1
$9.78M Buy
64,704
+33,347
+106% +$4.05M 0.05% 333
2025
Q4
$3.43M Buy
31,357
+18,671
+147% +$2.71M 0.02% 631
2025
Q3
$1.79M Buy
12,686
+2,621
+26% +$382K 0.01% 807
2025
Q2
$1.63M Buy
10,065
+1,009
+11% +$125K 0.01% 757
2025
Q1
$996K Buy
9,056
+4,633
+105% +$646K 0.01% 833
2024
Q4
$627K Buy
4,423
+2,822
+176% +$398K 0.01% 973
2024
Q3
$229K Buy
+1,601
New +$227K ﹤0.01% 1244

Other funds holding ARM

&Partners's ARM Position: Q2 2026 in Review

&Partners reduced its Arm (ARM) stake by 33% in Q2 2026, selling an estimated $5.61M and leaving 43,611 shares worth $15.5M. The position accounts for 0.06% of the portfolio, ranked #281.

&Partners first reported a position in ARM in Q3 2024 and has held it in 8 quarters since. 957 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • &Partners held 43,611 shares of Arm worth $15.5M as of Q2 2026.
  • &Partners sold 21,093 Arm shares in Q2 2026, an estimated $5.61M.
  • Arm made up 0.06% of &Partners's portfolio in Q2 2026, its #281 holding.
  • &Partners first reported a position in Arm in Q3 2024 and has held it in 8 quarters since.
  • 957 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.